Medtronic secures FDA clearance for LigaSure vessel sealer on Hugo robotic platform

Medtronic announced that the U.S. Food and Drug Administration has cleared its LigaSure RAS Maryland jaw vessel sealer-divider for use with the company's Hugo robotic-assisted surgery system.

The clearance allows surgeons to employ the familiar LigaSure technology, which can seal and cut vessels up to 7 mm in diameter in about two seconds while limiting thermal spread, within the Hugo platform.

Hugo is already cleared for urologic procedures in the United States and has been expanding across health systems. The addition of LigaSure aims to streamline workflow for surgeons transitioning from open or laparoscopic techniques to robotic surgery.

The device was first paired with Hugo in Europe after receiving a CE mark in 2025, and the FDA clearance brings the same capability to U.S. patients.